December 10th & 11th, 2026
15th edition
MARSEILLE, FR
Stand F10

2022 Edition

Paras Biopharmaceuticals Finland Oy

Finland

Company activities & offerings are categorized in 3 major areas:
1. Contract development & microbial biologics manufacturing (CDMO).
2. Development of Recombinant expression systems and process technologies for biologics and biosimilars.
3. Paras Biopharmaceuticals has developed and is offering Recombinant Bioprocess enzymes.

Scroll to Top

Before you leave…

Download the official BioFIT 2026 brochure

Discover the conference programme, partnership opportunities, attendee profiles, registration options and everything you need to make the most of BioFIT 2026.